Engaging the Private Sector
and Developing Partnerships to
Advance Health and the Sustainable
Development Goals
PROCEEDINGS OF A WORKSHOP SERIES
Rachel M. Taylor, Priyanka Nalamada, and Katherine Perez, Rapporteurs
Forum on Public—Private Partnerships for Global Health and Safety
Board on Global Health
Health and Medicine Division
THE NATIONAL ACADEMIES PRESS
Washington, DC
www.nap.edu
THE NATIONAL ACADEMIES PRESS500 Fifth Street, NWWashington, DC 20001
This project was supported by Anheuser-Busch InBev; Becton, Dickinson and Company; Bill & Melinda Gates Foundation; CARE USA; Catholic Health Association of the United States; Estée Lauder Companies; ExxonMobil; Fogarty International Center of the National Institutes of Health; General Electric; Global Health Innovative Technology Fund; Johnson & Johnson; Lockheed Martin Corporation; Medtronic; Merck; Novartis Foundation; PATH; PepsiCo; Procter & Gamble Co.; The Rockefeller Foundation; Safaricom; Takeda Pharmaceuticals; United Nations Foundation; University of Notre Dame; UPS Foundation; U.S. Agency for International Development; U.S. Department of Health and Human Services Office of Global Affairs; U.S. Department of State; U.S. Food and Drug Administration; Verizon Foundation; and The Vitality Group. Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project.
International Standard Book Number-13: 978-0-309-45804-7
International Standard Book Number-10: 0-309-45804-8
Digital Object Identifier: https://doi.org/10.17226/24744
Additional copies of this publication are available for sale from the National Academies Press, 500 Fifth Street, NW, Keck 360, Washington, DC 20001; (800) 624-6242 or (202) 334-3313; http://www.nap.edu.
Copyright 2017 by the National Academy of Sciences. All rights reserved.
Printed in the United States of America
Suggested citation: National Academies of Sciences, Engineering, and Medicine. 2017. Engaging the private sector and developing partnerships to advance health and the Sustainable Development Goals: Proceedings of a workshop series. Washington, DC: The National Academies Press. doi: https://doi.org/10.17226/24744.
The National Academy of Sciences was established in 1863 by an Act of Congress, signed by President Lincoln, as a private, nongovernmental institution to advise the nation on issues related to science and technology. Members are elected by their peers for outstanding contributions to research. Dr. Marcia McNutt is president.
The National Academy of Engineering was established in 1964 under the charter of the National Academy of Sciences to bring the practices of engineering to advising the nation. Members are elected by their peers for extraordinary contributions to engineering. Dr. C. D. Mote, Jr., is president.
The National Academy of Medicine (formerly the Institute of Medicine) was established in 1970 under the charter of the National Academy of Sciences to advise the nation on medical and health issues. Members are elected by their peers for distinguished contributions to medicine and health. Dr. Victor J. Dzau is president.
The three Academies work together as the National Academies of Sciences, Engineering, and Medicine to provide independent, objective analysis and advice to the nation and conduct other activities to solve complex problems and inform public policy decisions. The National Academies also encourage education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science, engineering, and medicine.
Learn more about the National Academies of Sciences, Engineering, and Medicine at www.nationalacademies.org.
Consensus Study Reports published by the National Academies of Sciences, Engineering, and Medicine document the evidence-based consensus on the study’s statement of task by an authoring committee of experts. Reports typically include findings, conclusions, and recommendations based on information gathered by the committee and the committee’s deliberations. Each report has been subjected to a rigorous and independent peer-review process and it represents the position of the National Academies on the statement of task.
Proceedings published by the National Academies of Sciences, Engineering, and Medicine chronicle the presentations and discussions at a workshop, symposium, or other event convened by the National Academies. The statements and opinions contained in proceedings are those of the participants and are not endorsed by other participants, the planning committee, or the National Academies.
For information about other products and activities of the National Academies, please visit www.nationalacademies.org/about/whatwedo.
PLANNING COMMITTEE ON ENGAGING THE PRIVATE SECTOR AND DEVELOPING PARTNERSHIPS TO ADVANCE HEALTH AND THE SDGs1
JO IVEY BOUFFORD (Co-Chair), President, The New York Academy of Medicine
RENUKA GADDE (Co-Chair), Vice President, Global Health, Becton, Dickinson and Company
SIR GEORGE ALLEYNE, Director Emeritus, Pan American Health Organization; Chancellor, University of the West Indies
RAJESH ANANDAN, Senior Vice President, Strategic Partnerships and UNICEF Ventures, U.S. Fund for UNICEF
CAROLINE BARRETT, Senior Officer, Global Health, United Nations Foundation
SIMON BLAND, Director, New York Liaison Office, UNAIDS
BRUCE COMPTON, Senior Director of International Outreach, Catholic Health Association of the United States
KATE DODSON, Vice President, Global Health Strategy, United Nations Foundation
BEN HOFFMAN, Chief Medical Officer, GE Energy
CLARION JOHNSON, Private Consultant and Physician, ExxonMobil
ALLISON TUMMON KAMPHUIS, Leader, Children’s Safe Drinking Water Program, Social Sustainability, Procter & Gamble Co.
NELSON SEWANKAMBO, Fellow and President, Uganda National Academy of Sciences; Former Dean, Makerere University
MARY LOU VALDEZ, Associate Commissioner for International Programs; Director, Office of International Programs, U.S. Food and Drug Administration
HOLLY WONG, Deputy Assistant Secretary for Global Affairs, U.S. Department of Health and Human Services
__________________
1 The National Academies of Sciences, Engineering, and Medicine’s planning committees are solely responsible for organizing the workshop, identifying topics, and choosing speakers. The responsibility for this published Proceedings of a Workshop Series rests with the workshop rapporteurs and the institution.
FORUM ON PUBLIC–PRIVATE PARTNERSHIPS FOR GLOBAL HEALTH AND SAFETY1
JO IVEY BOUFFORD (Co-Chair), President, The New York Academy of Medicine
CLARION JOHNSON (Co-Chair), Private Consultant, ExxonMobil
ANN AERTS, Head, Novartis Foundation
SIR GEORGE ALLEYNE, Director Emeritus, Pan American Health Organization; Chancellor, University of the West Indies
RAJESH ANANDAN, Senior Vice President, Strategic Partnerships and UNICEF Ventures, U.S. Fund for UNICEF
MARLEECE BARBER, Director of Health and Wellness and Chief Medical Officer, Lockheed Martin Corporation (until June 2016)
NATASHA BILIMORIA, Director, U.S. Strategy, Gavi, the Vaccine Alliance
DEBORAH L. BIRX, U.S. Global AIDS Coordinator and U.S. Special Representative for Global Health Diplomacy, U.S. Department of State, The United States President’s Emergency Plan for AIDS Relief
SIMON BLAND, Director, New York Liaison Office, UNAIDS
ROBERT BOLLINGER, Professor of Infectious Diseases, Johns Hopkins University School of Medicine
KIM C. BUSH, Director, Life Sciences Partnerships, Global Health Program, Bill & Melinda Gates Foundation (until January 2017)
STEPHEN CHEGE, Director, Corporate Affairs, Safaricom
GARY M. COHEN, Executive Vice President and President, Global Health and Development, Becton, Dickinson and Company
BRENDA D. COLATRELLA, Executive Director, Corporate Responsibility, Merck & Co., Inc.
BRUCE COMPTON, Senior Director of International Outreach, Catholic Health Association of the United States
PATRICIA DALY, Associate Vice President, Global Health, Save the Children
KATE DODSON, Vice President for Global Health Strategy, United Nations Foundation
ELAINE GIBBONS, Executive Director, Corporate Engagement, PATH
ROGER GLASS, Director, Fogarty International Center
DANIELLE GREENBERG, Senior Director, Global R&D; Senior Fellow, Nutrition Sciences, PepsiCo
___________________
1 The National Academies of Sciences, Engineering, and Medicine’s forums and roundtables do not issue, review, or approve individual documents. The responsibility for this published Proceedings of a Workshop Series rests with the workshop rapporteurs and the institution.
RICHARD GUERRANT, Thomas H. Hunter Professor of International Medicine, University of Virginia
TREVOR GUNN, Vice President, International Relations, Medtronic
JESSICA HERZSTEIN, Member, U.S. Preventive Services Task Force
BEN HOFFMAN, Chief Medical Officer, GE Energy
A. REZA JAFARI, Chairman and CEO, e-Development International
JAMES JONES, Manager, Community Investment Programs, ExxonMobil
ROSE STUCKEY KIRK, President, Verizon Foundation
SEEMA KUMAR, Vice President, Innovation, Global Health & Science Policy Communication, Johnson & Johnson
JOHN E. LANGE, Senior Fellow, Global Health Diplomacy, United Nations Foundation (until February 2017)
MARISSA LEFFLER, Senior Strategy and Innovation Advisor, Global Health Center for Accelerating Innovation and Impact, U.S. Agency for International Development
NANCY MAHON, Senior Vice President, Philanthropy and Social Initiatives, Estée Lauder Companies (until January 2017)
EDUARDO MARTINEZ, President, UPS Foundation
MICHAEL MYERS, Managing Director, The Rockefeller Foundation
ANDRIN OSWALD, Director, Life Sciences Partnerships, Bill & Melinda Gates Foundation
REGINA RABINOVICH, ExxonMobil Malaria Scholar in Residence, Harvard T.H. Chan School of Public Health
SCOTT C. RATZAN, President, Anheuser-Busch InBev Foundation
B. T. SLINGSBY, Chief Executive Officer and Executive Director, Global Health Innovative Technology Fund
KATHERINE TAYLOR, Associate Director and Director of Global Health Training, Eck Institute for Global Health, University of Notre Dame
WENDY TAYLOR, Director, Center for Accelerating Innovation and Impact, U.S. Agency for International Development (until January 2017)
ALLISON TUMMON KAMPHUIS, Leader, Children’s Safe Drinking Water Program, Social Sustainability, Procter & Gamble Co.
MARY LOU VALDEZ, Associate Commissioner for International Programs, Director, Office of International Programs, U.S. Food and Drug Administration
HOLLY WONG, Principal Deputy Assistant Secretary for Global Affairs, U.S. Department of Health and Human Services (until January 2017)
DEREK YACH, Chief Health Officer, The Vitality Group (until September 2017)
TADATAKA “TACHI” YAMADA, Venture Partner, Frazier Healthcare Partners
Health and Medicine Division Staff
RACHEL TAYLOR, Senior Program Officer and Forum Director
FRANCIS AMANKWAH, Research Associate (until October 2016)
PRIYANKA NALAMADA, Research Associate
KATHERINE PEREZ, Senior Program Assistant
FAYE HILLMAN, Financial Officer (until August 2017)
JULIE PAVLIN, Director, Board on Global Health
PATRICK W. KELLEY, Director, Board on Global Health (until July 2016)
Reviewers
This Proceedings of a Workshop Series was reviewed in draft form by individuals chosen for their diverse perspectives and technical expertise. The purpose of this independent review is to provide candid and critical comments that will assist the National Academies of Sciences, Engineering, and Medicine in making each published proceedings as sound as possible and to ensure that it meets the institutional standards for quality, objectivity, evidence, and responsiveness to the charge. The review comments and draft manuscript remain confidential to protect the integrity of the process.
We thank the following individuals for their review of this proceedings:
STUART MERKEL, Jhpiego, an affiliate of Johns Hopkins University
OLADOYIN ODUBANJO, The Nigerian Academy of Science
KATHLEEN SIENKO, University of Michigan Departments of Mechanical and Biomedical Engineering
Although the reviewers listed above provided many constructive comments and suggestions, they were not asked to endorse the content of the proceedings nor did they see the final draft before its release. The review of this proceedings was overseen by Martin J. Sepulveda, IBM. He was responsible for making certain that an independent examination of this proceedings was carried out in accordance with standards of the National Academies and that all review comments were carefully considered. Responsibility for the final content rests entirely with the rapporteurs and the National Academies.
This page intentionally left blank.
Acknowledgments
A number of individuals contributed to the development of this workshop and proceedings. These include a number of staff members from the Health and Medicine Division of the National Academies of Sciences, Engineering, and Medicine: Francis Amankwah, Faye Hillman, Patrick Kelley, Sarah Kelley, Priyanka Nalamada, Julie Pavlin, Katherine Perez, Bettina Ritter, and Rachel Taylor. The planning committee contributed several hours of service to develop and execute the agenda. Reviewers also provided thoughtful remarks in reading the draft manuscript.
The overall successful functioning of the Forum on Public–Private Partnerships for Global Health and Safety (PPP Forum) and its activities depends on the generosity of its sponsors. Financial support for the PPP Forum is provided by Anheuser-Busch InBev; Becton, Dickinson and Company; Bill & Melinda Gates Foundation; CARE USA; Catholic Health Association of the United States; Estée Lauder Companies; ExxonMobil; Fogarty International Center of the National Institutes of Health; General Electric; Global Health Innovative Technology Fund; Johnson & Johnson; Lockheed Martin Corporation; Medtronic; Merck; Novartis Foundation; PATH; PepsiCo; Procter & Gamble Co.; The Rockefeller Foundation; Safaricom; Takeda Pharmaceuticals; United Nations Foundation; University of Notre Dame; UPS Foundation; U.S. Agency for International Development; U.S. Department of Health and Human Services Office of Global Affairs; U.S. Department of State; U.S. Food and Drug Administration; Verizon Foundation; and The Vitality Group.
This page intentionally left blank.
Contents
Workshop Series and Organization of the Proceedings
2 HEALTH AND PRIVATE-SECTOR ENGAGEMENT IN THE SUSTAINABLE DEVELOPMENT GOALS
Evolving Collaboration in Health and Implications for the SDGs
Health, Economic Development, and Human Development Within the Context of the SDGs
Partnering with Business for Better Health and Development
Investments to Promote Country Ownership and Development in Africa
3 PUBLIC-SECTOR STRATEGIES AND PLANS FOR SUSTAINABLE DEVELOPMENT
Collaborative Approaches to Market-Based Solutions and Innovations to Finance the SDGs
Regulatory Systems to Support Sustainable Development
How Regulatory Systems Foster Development and Protect Citizens
The Role of Regulatory Systems in Enabling Industry Investments and Market Growth
How Regulatory Systems Protect and Sustain Contributions
Civil Society Engagement: Perspective from Save the Children
6 SEVERAL LESSONS FROM DEVELOPING AND IMPLEMENTING HEALTH-FOCUSED PARTNERSHIPS
Strengthening Laboratory Capacity to Scale Prevention, Treatment, and Care
Engaging at the Global Level to Catalyze Partnerships at the Local Level
This page intentionally left blank.
Boxes, Figures, and Table
BOXES
2-1 Measuring Development Beyond GDP
4-1 Perspectives from Other Sectors: University of Michigan
4-2 Perspectives from Other Sectors: Jhpiego
4-3 Perspectives from Other Sectors: United Nations Population Fund
4-4 Perspectives from Other Sectors: The U.S. President’s Emergency Plan for AIDS Relief
4-5 Spotlight Discussion with Andrew Jack, Financial Times
A-1 Case Study 1: Africa50 Infrastructure Fund
A-2 Case Study 2: HealthPhone, India
A-3 Case Study 3: The Dakar-Diamniadio Toll Road, Senegal
A-4 Case Study 4: Queen Mamohato Memorial Hospital, Lesotho
FIGURES
2-2 Deloitte private equity survey on opportunities over 12 months
5-1 General process in high-income countries (a)
5-2 General process in low-income countries (b)
5-3 Vision and key strategic axes
5-4 Elements of an action cycle
A-1 Private participation in infrastructure projects and investment commitments, 1990-2014
TABLE
5-1 Components of Regulatory Design and Accompanying Forms of Government Intervention
Acronyms and Abbreviations
AB InBev | Anheuser-Busch InBev |
AMRH | African Medicines Regulatory Harmonisation |
BD | Becton, Dickinson and Company |
BT | British Telecom |
CDC | U.S. Centers for Disease Control and Prevention |
CHAI | Clinton Health Access Initiative |
CPI | Consumer Price Index |
CSR | corporate social responsibility |
DfID | UK’s Department for International Development |
EAC | East African Community |
EPAD | New Partnership for Africa’s Development |
FDA | U.S. Food and Drug Administration |
FDI | foreign direct investment |
FENSA | Framework of Engagement with Non-State Actors |
GAIN | Global Alliance for Improved Nutrition |
GCC | Grand Challenges Canada |
GDP | gross domestic product |
GHDI | Global Health Design Initiative |
GHIF | Global Health Investment Fund |
HDI | Human Development Index |
HiAP | Health in All Policies |
HIV/AIDS | human immunodeficiency virus/acquired immunodeficiency syndrome |
HLPF | High-Level Political Forum |
ICT | information and communication technology |
INGO | international nongovernmental organization |
IoT | Internet of Things |
LMIC | low- and middle-income country |
MAPS | mainstreaming, acceleration, and policy support |
MDG | Millennium Development Goal |
NASEM | National Academies of Sciences, Engineering, and Medicine |
NCD | noncommunicable disease |
NGO | nongovernmental organization |
NRA | national regulatory authority |
P&G | Procter & Gamble Co. |
PAHO | Pan American Health Organization |
PEPFAR | The U.S. President’s Emergency Plan for AIDS Relief |
PPDP | public–private development partnership |
PPP | public–private partnership |
SDG | Sustainable Development Goal |
SLIPTA | Stepwise Laboratory Improvement Process Towards Accreditation |
TB | tuberculosis |
UIA | Uganda Investment Authority |
UK | United Kingdom |
UN | United Nations |
UNAS | Uganda National Academy of Sciences |
UNDP | UN Development Programme |
UNFPA | UN Population Fund |
UPS | United Parcel Service |
USAID | U.S. Agency for International Development |
WBA | Wireless Broadband Alliance |
WDI | William Davidson Institute |
WHO | World Health Organization |
This page intentionally left blank.